Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.48 |
| ▸ | GABRD | O14764 | 2/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.48 |
| ▸ | GABRE | P78334 | 2/20 | 0.48 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.48 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.48 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.48 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29564893 | 0.89 | GABRP (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4959221 | 0.87 | GRM8 (0.62) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL496858 | 0.87 | GRM8 (0.62) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1537429 | 0.86 | SLC7A5 (0.44) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2695665 | 0.86 | ALOX15 (0.47) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL12497981 | 0.86 | ALOX15 (0.47) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL3402553 | 0.85 | GABRP (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL10636419 | 0.85 | GRM8 (0.60) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL995721 | 0.84 | SLC7A5 (0.58) | SLC1A3SLC1A2SLC7A5SLC1A1DPP4 | |
| SCHEMBL9100153 | 0.84 | SLC7A5 (0.58) | SLC1A3SLC1A2SLC7A5SLC1A1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122045749-A | Method for identifying key flavor substances of rice based on materially group science and machine learning | 华中农业大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20250000364-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | GLAS USA LLC | 2025-01-02 | — | — | US | disclosed |
| US-12089916-B2 | Gastrointestinal tract detection methods, devices and systems | BIORA THERAPEUTICS, INC. (US) | 2024-09-17 | — | — | US | disclosed |
| EP-4252629-A2 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | Biora Therapeutics, Inc. (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-3551046-B1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | BIORA THERAPEUTICS INC (US) | 2023-07-19 | — | — | EP | disclosed |
| US-20230009902-A1 | TREATMENT OF A DISEASE OR CONDITION IN A TISSUE ORGINATING FROM THE ENDODERM | GLAS USA LLC | 2023-01-12 | — | — | US | disclosed |
| US-11547301-B2 | Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract | BIORA THERAPEUTICS, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-20220273196-A1 | INGESTIBLE DEVICE AND ASSOCIATED METHODS | GLAS USA LLC | 2022-09-01 | — | — | US | disclosed |
| CN-114269951-A | Diagnostic method for aesthetic deterioration of skin | 欧莱雅 | 2022-04-01 | — | — | CN | disclosed |
| US-11224364-B2 | Ingestible device and associated methods | PROGENITY, INC. (US) | 2022-01-18 | — | — | US | disclosed |
| WO-2018106945-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | PROGENITY INC. (US) | 2018-06-14 | — | — | WO | disclosed |
| US-9977034-B2 | Biomarkers for fatty liver disease and methods using the same | Meabolon, Inc. (US) | 2018-05-22 | — | — | US | disclosed |
| US-20150377910-A1 | Biomarkers for Fatty Liver Disease and Methods Using the Same | METABOLON, INC. | 2015-12-31 | — | — | US | disclosed |
| US-20100279956-A1 | Biomarkers For Fatty Liver Disease And Methods Using The Same | METABOLON, INC. | 2010-11-04 | — | — | US | disclosed |
| EP-2225386-A2 | PROCESS FOR THE ENZYMATIC PREPARATION OF A GAMMA-GLUTAMYL COMPOUND | Unilever PLC (GB) | 2010-09-08 | — | — | EP | disclosed |
| WO-2009083454-A2 | PROCESS FOR THE ENZYMATIC PREPARATION OF A GAMMA-GLUTAMYL COMPOUND | UNILEVER PLC (GB) | 2009-07-09 | — | — | WO | disclosed |
| US-20090169704-A1 | Process for the enzymatic preparation of a gamma-glutamyl compound | CONOPCO, INC. D/B/A UNILEVER | 2009-07-02 | — | — | US | disclosed |
| EP-0883629-A1 | OLIGOPEPTIDES FOR DRUG DELIVERY | Emisphere Technologies, Inc. (US) | 1998-12-16 | — | — | EP | disclosed |
| WO-1997031938-A9 | OLIGOPEPTIDES FOR DRUG DELIVERY | — | 1997-11-20 | — | — | WO | disclosed |
| WO-1997031938-A1 | OLIGOPEPTIDES FOR DRUG DELIVERY | EMISPHERE TECHNOLOGIES, INC. (US) | 1997-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12089916-B2 | Gastrointestinal tract detection methods, devices and systems | FABP2, SI, MLNR | GABRP 3314/4885GABRD 2536/4885GABRA1 2930/4885 |
| US-11547301-B2 | Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract | SI, VIP, MLN | GABRP 4505/4885GABRD 3520/4885GABRA1 4248/4885 |
| US-20250000364-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | FABP2, SI, MLNR | GABRP 3314/4885GABRD 2536/4885GABRA1 2930/4885 |
| US-20230009902-A1 | TREATMENT OF A DISEASE OR CONDITION IN A TISSUE ORGINATING FROM THE ENDODERM | ALPG, ALPP, FABP2 | GABRP 4597/4885GABRD 3894/4885GABRA1 4208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.